DUFIL SUPPORTS 200 SICKLE CELL PATIENTS WITH MEDICATION

Dufil Prima Foods Plc has provided medication and other forms of support to 200 sickle cell patients as part of its efforts to improve access to healthcare for people living with the condition.

The intervention is aimed at helping beneficiaries manage the condition and reduce the financial burden associated with regular medication and healthcare needs.

The company said the initiative forms part of its corporate social responsibility efforts and reflects its commitment to supporting vulnerable members of society.

Healthcare stakeholders welcomed the intervention, noting that consistent access to medication is important for people living with sickle cell disease.

They also stressed the need for greater awareness, early diagnosis, affordable healthcare, and sustained support for affected families.

The initiative highlights the role of private-sector organisations in complementing government and healthcare institutions through targeted community health programmes.

Dufil said it would continue to support initiatives that improve healthcare access and contribute to the wellbeing of communities where it operates.

Stakeholders urged other organisations to support sickle cell programmes and invest in healthcare initiatives that can improve the quality of life of affected Nigerians.